104 related articles for article (PubMed ID: 2242754)
1. In vitro human cytotoxic T cell responses against influenza A virus can be induced and selected by synthetic peptides.
Martinon F; Gomard E; Hannoun C; Lévy JP
Eur J Immunol; 1990 Oct; 20(10):2171-6. PubMed ID: 2242754
[TBL] [Abstract][Full Text] [Related]
2. A single amino acid substitution in HLA-A2 can alter the selection of the cytotoxic T lymphocyte repertoire that responds to influenza virus matrix peptide 55-73.
Shimojo N; Cowan EP; Engelhard VH; Maloy WL; Coligan JE; Biddison WE
J Immunol; 1989 Jul; 143(2):558-64. PubMed ID: 2472444
[TBL] [Abstract][Full Text] [Related]
3. Overlapping epitopes that are recognized by CD8+ HLA class I-restricted and CD4+ class II-restricted cytotoxic T lymphocytes are contained within an influenza nucleoprotein peptide.
Carreno BM; Turner RV; Biddison WE; Coligan JE
J Immunol; 1992 Feb; 148(3):894-9. PubMed ID: 1370522
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxic T lymphocytes recognize a fragment of influenza virus matrix protein in association with HLA-A2.
Gotch F; Rothbard J; Howland K; Townsend A; McMichael A
Nature; 1987 Apr 30-May 6; 326(6116):881-2. PubMed ID: 2437457
[TBL] [Abstract][Full Text] [Related]
5. HLA A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection.
Nayersina R; Fowler P; Guilhot S; Missale G; Cerny A; Schlicht HJ; Vitiello A; Chesnut R; Person JL; Redeker AG; Chisari FV
J Immunol; 1993 May; 150(10):4659-71. PubMed ID: 7683326
[TBL] [Abstract][Full Text] [Related]
6. Anti-HLA-A2 antibody-enhancement of peptide association with HLA-A2 as detected by cytotoxic T lymphocytes.
Bodmer H; Ogg G; Gotch F; McMichael A
Nature; 1989 Nov; 342(6248):443-6. PubMed ID: 2479838
[TBL] [Abstract][Full Text] [Related]
7. Identification of peptide sequences that potentially trigger HLA-A2.1-restricted cytotoxic T lymphocytes.
Nijman HW; Houbiers JG; Vierboom MP; van der Burg SH; Drijfhout JW; D'Amaro J; Kenemans P; Melief CJ; Kast WM
Eur J Immunol; 1993 Jun; 23(6):1215-9. PubMed ID: 7684681
[TBL] [Abstract][Full Text] [Related]
8. Human cytotoxic T lymphocytes stimulated by endogenously processed human papillomavirus type 11 E7 recognize a peptide containing a HLA-A2 (A*0201) motif.
Tarpey I; Stacey S; Hickling J; Birley HD; Renton A; McIndoe A; Davies DH
Immunology; 1994 Feb; 81(2):222-7. PubMed ID: 8157270
[TBL] [Abstract][Full Text] [Related]
9. HLA-A2-restricted cytotoxic T lymphocyte responses to multiple Plasmodium falciparum sporozoite surface protein 2 epitopes in sporozoite-immunized volunteers.
Wizel B; Houghten R; Church P; Tine JA; Lanar DE; Gordon DM; Ballou WR; Sette A; Hoffman SL
J Immunol; 1995 Jul; 155(2):766-75. PubMed ID: 7541824
[TBL] [Abstract][Full Text] [Related]
10. Genetic evidence for difference between intracellular and extracellular peptides in influenza A matrix peptide-specific CTL recognition.
Matsui M; Moots RJ; Warburton RJ; Peace-Brewer AL; Tussey LG; Quinn DG; McMichael AJ; Frelinger JA
J Immunol; 1995 Feb; 154(3):1088-96. PubMed ID: 7822785
[TBL] [Abstract][Full Text] [Related]
11. Peptide-pulsed dendritic cells induce tumoricidal cytotoxic T lymphocytes from healthy donors against stably HLA-A*0201-binding peptides from the Melan-A/MART-1 self antigen.
van Elsas A; van der Burg SH; van der Minne CE; Borghi M; Mourer JS; Melief CJ; Schrier PI
Eur J Immunol; 1996 Aug; 26(8):1683-9. PubMed ID: 8765006
[TBL] [Abstract][Full Text] [Related]
12. Identification of the nonamer peptide from influenza A matrix protein and the role of pockets of HLA-A2 in its recognition by cytotoxic T lymphocytes.
Morrison J; Elvin J; Latron F; Gotch F; Moots R; Strominger JL; McMichael A
Eur J Immunol; 1992 Apr; 22(4):903-7. PubMed ID: 1372560
[TBL] [Abstract][Full Text] [Related]
13. Identification of an enhancer agonist cytotoxic T lymphocyte peptide from human carcinoembryonic antigen.
Zaremba S; Barzaga E; Zhu M; Soares N; Tsang KY; Schlom J
Cancer Res; 1997 Oct; 57(20):4570-7. PubMed ID: 9377571
[TBL] [Abstract][Full Text] [Related]
14. Induction in vitro of a primary human antiviral cytotoxic T cell response.
Cerny A; Fowler P; Brothers MA; Houghton M; Schlicht HJ; Chisari FV
Eur J Immunol; 1995 Feb; 25(2):627-30. PubMed ID: 7875224
[TBL] [Abstract][Full Text] [Related]
15. Endogenous loading of HLA-A2 molecules with an analog of the influenza virus matrix protein-derived peptide and its inhibition by an exogenous peptide antagonist.
Gammon MC; Bednarek MA; Biddison WE; Bondy SS; Hermes JD; Mark GE; Williamson AR; Zweerink HJ
J Immunol; 1992 Jan; 148(1):7-12. PubMed ID: 1727876
[TBL] [Abstract][Full Text] [Related]
16. Influenza A-specific, HLA-A2.1-restricted cytotoxic T lymphocytes from HLA-A2.1 transgenic mice recognize fragments of the M1 protein.
Engelhard VH; Lacy E; Ridge JP
J Immunol; 1991 Feb; 146(4):1226-32. PubMed ID: 1704033
[TBL] [Abstract][Full Text] [Related]
17. Synthetic peptides induce a cytotoxic response against human papillomavirus type-18.
Castellanos MR; Hayes RL; Maiman MA
Gynecol Oncol; 2001 Jul; 82(1):77-83. PubMed ID: 11426965
[TBL] [Abstract][Full Text] [Related]
18. Generation of human cytolytic T lymphocyte lines directed against prostate-specific antigen (PSA) employing a PSA oligoepitope peptide.
Correale P; Walmsley K; Zaremba S; Zhu M; Schlom J; Tsang KY
J Immunol; 1998 Sep; 161(6):3186-94. PubMed ID: 9743387
[TBL] [Abstract][Full Text] [Related]
19. Comparison between two peptide epitopes presented to cytotoxic T lymphocytes by HLA-A2. Evidence for discrete locations within HLA-A2.
Robbins PA; Lettice LA; Rota P; Santos-Aguado J; Rothbard J; McMichael AJ; Strominger JL
J Immunol; 1989 Dec; 143(12):4098-103. PubMed ID: 2480387
[TBL] [Abstract][Full Text] [Related]
20. CTL responses of HLA-A2.1-transgenic mice specific for hepatitis C viral peptides predict epitopes for CTL of humans carrying HLA-A2.1.
Shirai M; Arichi T; Nishioka M; Nomura T; Ikeda K; Kawanishi K; Engelhard VH; Feinstone SM; Berzofsky JA
J Immunol; 1995 Mar; 154(6):2733-42. PubMed ID: 7533182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
